Alterola Biotech Company Description

Alterola Biotech, Inc., a pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules.

It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability.

Alterola Biotech, Inc. is based in Birkenhead, the United Kingdom.

Alterola Biotech, Inc.

Country	United States
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	1
CEO	David Hitchcock

Contact Details

Address: 47 Hamilton Square Birkenhead, Nevada CH41 5AR United Kingdom
Phone	44 1516 019 477
Website	alterola-abti.com

Stock Details

Ticker Symbol	ABTI
Exchange	OTCMKTS
Stock Type	Common Stock
Fiscal Year	April - March
Reporting Currency	USD
ISIN Number	US02152V1035
SIC Code	2834

Key Executives

Name	Position
David John Hitchcock O.B.E.	Chief Executive Officer and Director
Timothy Paul Rogers	Executive Chairman
Nathan Thompson	Chief Financial Officer, Secretary and Director
Colin G. Stott B.Sc.	Chief Operating Officer and Director
Dominic Schiller	IP Counsel, Chief IP Officer and Director